Quantitative assay for the determination of apo E in serum and plasma

Journal of Clinical Ligand Assay

Volumn 19, Issue 3, 1996, Pages 172-176

  Krassnoff, Paul ^a   Pisani, Thomas ^a   Long, Susan ^a  

^a GENZYME CORPORATION   (United States)

Author keywords

Apo E; Apolipoproteins; ELISA; Immunoassay

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; LIPOPROTEIN BLOOD LEVEL; QUANTITATIVE DIAGNOSIS; REVIEW;

EID: 0030485127     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Davignon J: Apolipoprotein E polymorphism and atherosclerosis, in Born CVR, Schwartz CH (eds): New horizons in coronary heart disease, Current Science 1993, 5.1-5.21.
2. Weisgraber KH, Roses AD, Strittmatter WJ: The role of apolipoprotein E in the nervous system. Current Opinion in Lipldology 1994;5:110-116.
3. Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232:36-47.
4. Beisiegel U, Weber W, Ihrke G, et al: The LDL-receptor related protein, LRP, is an apolipoprotein E binding protein. Nature 1989;341:162-164.
5. Rall SC, Weisgraber KH, Mahley RW: Human apolipoprotein E heterogeneity. J Bio Chem 1981;256:9077-9083.
6. Rall SC, Mahley RW: The role of apolipoprotein E genetic variants in lipoprotein disorders. J Internal Med 1992;231:653-659.
7. Wisniewski T, Golabek A, Matsubara E, et al: Apolipoprotein E: Binding to soluble Alzheimer's β-amyloid. Biochem Biophys Res Communications 1993;192(2):359.
8. Strittmatter WJ, Weisgraber K, Huang DY, et al: Binding of human apolipoprotein E to synthetic amyloid β-amyloid peptide: Isoform-specific effects and implication for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:8098.
9. Utermann G, Hees M, Steinmetz A: Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature 1977;269:604-607.
10. Zannis VI, Breslow JL, Utermann G, et al: Proposed nomenclature of apo E isoproteins, apo E genotypes and phenotypes. Journal of Lipid Research 1982;23:911-914.
11. Reilly SL, Ferrell RE, Kottke BA, et al: The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleitropic effects on means and variances. Am J Hum Genet 1993;49:1155-1166.
12. Ordovas JM, Lopez de Yela A, Lahoz C, et al: Distribution of apo E in plasma lipoproteins is a major determinant of triglyceride, HDL cholesterol and LDL particle size in the Framingham Offspring Study. Circulation 1996;I-93.
13. Bury J, Rosseneu M: Quantification of human serum apolipoprotein AI by enzyme immunoassay. Clinical Chemistry 1985;32:247-251.
14. Cohn JS, Tremblay M, Amoit M, et al: Plasma Concentration of Apolipoprotein E in intermediate-sized remnant-like lipoproteins in normalpidemic and hyperlipidemic subjects. Arteriosclerosis, Thrombosis and Vascular Biology 1996;16:149.
15. Clinical Diagnosis and Management by Laboratory Methods 19th Edition. Henry, JB (ed), W.B. Saunder Co., 1996.
16. Chiba H, Eto M, Fujisawa SI, et al: Increased plasma apolipoprotein E-rich high-density lipoprotein and its effect on serum high-density lipoprotein cholesterol determination in patients with familial hyperalphalipoproteinemia due to cholesteryl ester transfer activity deficiency. Biochemical Medicine and Metabolic Biology 1993;49:79-89.